Bausch + Lomb BLCO Devices — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch + Lomb in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch + Lomb's devices — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bausch + Lomb's devices — total revenues?
- Bausch + Lomb (BLCO) reported devices — total revenues of $480M in Q1 2026.
- How has Bausch + Lomb's devices — total revenues changed year-over-year?
- Bausch + Lomb's devices — total revenues increased by 7.1% year-over-year, from $448M to $480M.
- What is the long-term trend for Bausch + Lomb's devices — total revenues?
- Over 4 years (2021 to 2025), Bausch + Lomb's devices — total revenues has grown at a 4.8% compound annual growth rate (CAGR), from $1.6B to $1.92B.
- What does devices — total revenues mean?
- This metric represents the total gross revenue generated from the sale of surgical equipment, intraocular lenses, and related medical devices within the company's surgical segment. It serves as a primary indicator of market penetration and demand for the firm's specialized ophthalmic hardware and surgical solutions. Tracking this figure helps investors assess the segment's growth trajectory and its contribution to the overall corporate revenue mix.